U.S. Neurosurgical Holdings, Inc.
USNU
$0.83
-$0.005-0.60%
OTC PK
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 27.65% | -11.44% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 27.65% | -11.44% | |||
| Operating Income | -27.65% | 11.44% | |||
| Income Before Tax | -252.07% | 33.33% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -252.07% | 33.33% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -252.07% | 33.33% | |||
| EBIT | -27.65% | 11.44% | |||
| EBITDA | -- | -- | |||
| EPS Basic | -154.97% | 47.06% | |||
| Normalized Basic EPS | -154.21% | 47.03% | |||
| EPS Diluted | -154.97% | 47.06% | |||
| Normalized Diluted EPS | -154.21% | 47.03% | |||
| Average Basic Shares Outstanding | 37.79% | 26.12% | |||
| Average Diluted Shares Outstanding | 37.79% | 26.12% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||